Stay updated on Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page.

Latest updates to the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check65 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed clinical information regarding the treatment of metastatic germ cell tumors and the addition of a new study identifier and location. The revision number has also been updated.SummaryDifference50%
Stay in the know with updates to Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page.